Abstract
A prospective longitudinal study was conducted in 14 premature infants intubated and receiving ventilatory support from birth, in order to evaluate the levels of prostaglandins E2 (PGE2) and thromboxane B2 (TxB2) in the tracheal lavage fluids (TLF) after treatment with indomethacin. Eight were treated with indomethacin, a cyclooxygenase inhibitor, for patent ductus arteriosus and the others served as controls. Infants who received indomethacin during the first postnatal week had significantly lower levels of eicosanoids in TLF during the first week. Our results suggest that levels of eicosanoids in TLF of premature infants are related to an inflammatory reaction and may serve as an index of the infant's overall clinical condition.
Similar content being viewed by others
References
Hanley, S. P. 1986. Prostaglandin and the lung.Lung 164:65–77.
Demling, R. H., M. Smith, R. Gunther, J. T. Flynn, andM. H. Gee. 1981. Pulmonary injury and prostaglandin production during endotoxenia in concious sheep.Am. J. Physiol. 240:H348-H353.
Perkowski, S. Z., A. M. Havill, J. T. Flynn, andM. H. Gee. 1983. Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation.Circ. Res. 53:574–583.
Robidoux, C., J. Maclouf, P. Pradelles, andP. Sirois. 1988. Release of prostaglandin E2 and thromboxane B2 by mixed isolated human lung cells.Prostaglandins, Leukotrienes, Essent. Fatty Acids 32:23–28.
Ashbaugh, D. G., D. B. Bigelow, T. L. Petty, andB. E. Levine. 1967. Acute respiratory distress in adults.Lancet 2:319–323.
Stenmark, K. R., M. Eyzaguirre, J. Y. Wescott, P. M. Henson, andR. C. Murphy. 1987. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia.Am. Rev. Respir. Dis. 136:770–772.
Merrit, T. A., C. G. Cochrane, K. Holcomb, B. Bohl, M. Hallman, K. Strayer, D. K. Edwards, III, andL. Gluck. 1983. Elastase and α1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.J. Clin. Invest. 72:656–666.
Bonikos, D. S., K. G. Bensch, W. H. Northway, Jr., andD. K. Edwards, III. 1976. Bronchopulmonary dysplasia: The pulmonary pathologic sequel of necrotising bronchiolitis and pulmonary fibrosis.Hum. Pathol. 7:643–666.
Pradelles, P., J. Grassi, andJ. Maclouf. 1985. Enzyme immunoassays of eicosanoids using acetylcholinesterase as label: An alternative to radio-immunoassay.Anal. Chem. 57:1170–1173.
Vane, J. R. 1971. Inhibition of prostaglandin synthesis as mechanism of action for aspirinlike drugs.Nature, (London), New Biol. 231:232–235.
Friedman, C. A., B. R. Parks, J. E. Rawson, G. A. Serwer, andP. A. Anderson. 1982. Indomathacin and the preterm infant with a patent ductus arteriosus: Relationship between plasma concentration and ductus closure.Dev. Pharmacol. Ther. 4:37–46.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Le Guennec, J.C., Lauzière, M., Black, R. et al. Effects of indomethacin on prostaglandin E2 and thromboxane B2 contents of tracheal lavage fluids in premature infants. Inflammation 15, 55–59 (1991). https://doi.org/10.1007/BF00917909
Issue Date:
DOI: https://doi.org/10.1007/BF00917909